Chemokine production by human megakaryocytes derived from CD34-positive cord blood cells.
To clarify the roles of megakaryocytes and platelets in the responses associated with infection and inflammation, we examined the effects of interleukin (IL) 1, the common mediator of the inflammatory process, on the development and secretory functions of megakaryocytes generated from CD34(+)cord blood cells under stimulation with thrombopoietin (TPO). The addition of IL-1alpha did not influence the generation, endomitosis or expression of surface makers of megakaryocytes, compared with TPO alone. However, IL-1alphaenhanced the ability of megakaryocytes to produce IL-8 and growth-regulating oncogene-alpha(GRO-alpha) in the presence of TPO. In contrast, the production of regulated on activation with normal T cell expressed and secreted (RANTES), platelet factor 4 (PF4) and beta-thromboglobulin (beta-TG) were not potentiated. A flow cytometric analysis and a reverse transcription-polymerase chain reaction analysis revealed IL-1 receptor type I (IL-1RI) expression of megakaryocytes generated by TPO. Moreover, the addition of an anti-IL-1RI monoclonal antibody significantly decreased the TPO plus IL-1alpha-induced secretion of IL-8 by the cultured megakaryocytes to the level attained by TPO alone. These results suggest that the production of IL-8 and GRO-alpha (but not RANTES), PF4 and beta-TG, by megakaryocytes is potentiated by signalling through IL-1RI with the aid of TPO. Thus, megakaryocytes and platelets may play an important role in the development of inflammation via chemokine release.
Takeuchi
K
K
Department of Pediatrics, Shinshu University School of Medicine, Matsumoto, Japan.
Higuchi
T
T
Yamashita
T
T
Koike
K
K
D018952:Antigens, CD34 / Q000097:blood*; D002478:Cells, Cultured; D018946:Chemokine CCL5 / Q000096:biosynthesis; D018925:Chemokines / Q000096:biosynthesis*; D005312:Fetal Blood / Q000166:cytology / Q000276:immunology / Q000378:metabolism*; D006133:Growth Substances / Q000096:biosynthesis / Q000235:genetics; D006801:Humans; D007375:Interleukin-1 / Q000494:pharmacology; D016209:Interleukin-8 / Q000096:biosynthesis; D008533:Megakaryocytes / Q000187:drug effects* / Q000378:metabolism; D010978:Platelet Factor 4 / Q000096:biosynthesis; D013926:Thrombopoietin / Q000494:pharmacology; D001620:beta-Thromboglobulin / Q000096:biosynthesis
D018952:Antigens, CD34; D018946:Chemokine CCL5; D018925:Chemokines; D006133:Growth Substances; D007375:Interleukin-1; D016209:Interleukin-8; D001620:beta-Thromboglobulin; D010978:Platelet Factor 4; D013926:Thrombopoietin